0000950170-24-001141.txt : 20240103 0000950170-24-001141.hdr.sgml : 20240103 20240103172152 ACCESSION NUMBER: 0000950170-24-001141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kling Douglas F CENTRAL INDEX KEY: 0001699022 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41562 FILM NUMBER: 24508219 MAIL ADDRESS: STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC. STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V. CENTRAL INDEX KEY: 0001936258 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC BUSINESS PHONE: 35 206 2971 MAIL ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC FORMER COMPANY: FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V. DATE OF NAME CHANGE: 20220701 4 1 ownership.xml 4 X0508 4 2024-01-01 0001936258 NewAmsterdam Pharma Co N.V. NAMS 0001699022 Kling Douglas F C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35 NAARDEN P7 1411 DC NETHERLANDS false true false false Chief Operating Officer false Option (right to buy) 11.17 2024-01-01 4 A false 323771 0.00 A 2034-01-01 Ordinary Shares 323771 323771 D 25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date. /s/ Louise Kooij by Power of Attorney from Douglas F. Kling 2024-01-03